Revenue

6 Months Ended

Sep. 30, 2020

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

Revenue Recognition

The following table presents DXC's revenues disaggregated by geography, based on the location of incorporation of the DXC entity providing the related goods or services:

	Three Months Ended				Six Months Ended
(in millions)	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019
United States	$	1,666	$	1,806	$	3,375	$	3,657
United Kingdom	579		678		1,152		1,393
Other Europe	1,244		1,260		2,449		2,490
Australia	390		366		751		739
Other International	675		741		1,329		1,462
Total Revenues	$	4,554	$	4,851	$	9,056	$	9,741

The revenue by geography pertains to both of the Company’s reportable segments. Refer to Note 20 - "Segment Information" for the Company’s segment disclosures.

Remaining Performance Obligations

Remaining performance obligations represent the aggregate amount of the transaction price in contracts allocated to performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Remaining performance obligation estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue that have not materialized and adjustments for currency. As of September 30, 2020, approximately $23 billion of revenue is expected to be recognized from remaining performance obligations. We expect to recognize revenue on approximately 25% of these remaining performance obligations in fiscal 2021, with the remainder of the balance recognized thereafter.

Contract Balances

The following table provides information about the balances of the Company's trade receivables and contract assets and contract liabilities:

	As of
(in millions)	September 30, 2020		March 31, 2020
Trade receivables, net	$	2,950	$	3,059
Contract assets	$	413	$	454
Contract liabilities	$	1,671	$	1,756

Change in contract liabilities were as follows:

	Six Months Ended
(in millions)	September 30, 2020		September 30, 2019
Balance, beginning of period	$	1,756	$	1,886
Deferred revenue	1,355		1,400
Recognition of deferred revenue	(1,432)		(1,416)
Currency translation adjustment	80		(48)
Other(1)	(88)		(22)
Balance, end of period	$	1,671	$	1,800

(1) Other includes $51 million of contract liabilities reclassified as liabilities related to assets held for sale on the Consolidated Balance Sheet,

in conjunction with HHS Business classified as assets held for sale.